HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean-Louis Montero Selected Research
Jean-Louis Montero Research Topics
Disease
28
Neoplasms (Cancer)
06/2013 - 05/2003
4
Hypoxia (Hypoxemia)
05/2008 - 07/2005
3
Glaucoma
03/2007 - 01/2004
2
Infections
05/2011 - 03/2005
2
Obesity
01/2008 - 03/2005
2
Atherosclerosis
06/2006 - 03/2005
1
Carcinogenesis
07/2009
1
Persistent Infection
07/2007
1
Pathologic Processes
08/2006
1
Stroke (Strokes)
06/2006
1
Myocardial Infarction
06/2006
1
Cicatrix (Scar)
05/2006
1
Breast Neoplasms (Breast Cancer)
03/2005
1
Hyperlipidemias (Hyperlipidemia)
03/2005
1
Prostatic Neoplasms (Prostate Cancer)
03/2005
1
Weight Loss (Weight Reduction)
03/2005
1
Renal Cell Carcinoma (Grawitz Tumor)
11/2004
1
Melanoma (Melanoma, Malignant)
11/2003
1
Carcinoma (Carcinomatosis)
10/2003
1
Leukemia
12/2002
Drug/Important Bio-Agent (IBA)
20
Carbonic Anhydrases (Carbonic Anhydrase)
IBA
05/2011 - 05/2003
20
Isoenzymes
IBA
09/2009 - 05/2003
15
Protein Isoforms (Isoforms)
IBA
06/2013 - 07/2005
13
Sulfonamides
IBA
05/2011 - 01/2004
13
Carbonic Anhydrase Inhibitors
IBA
09/2009 - 12/2003
9
Enzymes
IBA
05/2011 - 05/2003
5
Zinc
IBA
08/2006 - 05/2003
2
Boron
IBA
05/2011 - 07/2005
2
Carbonic Anhydrase IX
IBA
07/2009 - 07/2005
2
Copper
IBA
11/2008 - 01/2008
2
Carbon Dioxide
IBA
05/2008 - 08/2006
2
Bicarbonates (Hydrogen Carbonate)
IBA
05/2008 - 08/2006
2
Anti-Bacterial Agents (Antibiotics)
IBA
07/2007 - 03/2005
2
sparfosic acid (PALA)
IBA
03/2005 - 10/2003
2
sulfamic acid (ammonium sulfamate)
IBA
03/2005 - 12/2003
2
Steroids
IBA
03/2005 - 05/2003
2
Sulfatases
IBA
03/2005 - 05/2003
1
Virulence Factors (Pathogenicity Factors)
IBA
05/2011
1
Ketones
IBA
05/2011
1
boroxazolidone
IBA
05/2011
1
Phenols
IBA
09/2009
1
diphenyl (biphenyl)
IBA
05/2009
1
Boronic Acids
IBA
05/2009
1
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
IBA
11/2008
1
Pentetic Acid (DTPA)
FDA Link
Generic
11/2008
1
Protons (Proton)
IBA
05/2008
1
Metals
IBA
05/2008
1
Transcription Factors (Transcription Factor)
IBA
05/2008
1
Amides
IBA
09/2006
1
Sulfhydryl Compounds (Thiols)
IBA
09/2006
1
Nitrogen
IBA
09/2006
1
Disulfides
IBA
09/2006
1
Diuretics
IBA
08/2006
1
Anti-Ulcer Agents
IBA
08/2006
1
Antiglaucoma Agents
IBA
08/2006
1
Anti-Obesity Agents (Antiobesity Drugs)
IBA
08/2006
1
Thromboxanes
IBA
06/2006
1
Arachidonic Acid (Vitamin F)
IBA
06/2006
1
Phosphates (Orthophosphate)
IBA
05/2006
1
IGF Type 2 Receptor (Insulin-Like-Growth-Factor II Receptor)
IBA
05/2006
1
Mannose (D-Mannose)
IBA
05/2006
1
Transforming Growth Factor beta (TGF-beta)
IBA
05/2006
1
Proteins (Proteins, Gene)
FDA Link
03/2005
1
Transfer RNA (tRNA)
IBA
03/2005
1
Pharmaceutical Preparations
IBA
03/2005
1
Hormones (Hormone)
IBA
03/2005
1
Ligases (Synthetase)
IBA
03/2005
1
Topiramate (Topamax)
FDA Link
Generic
03/2005
1
avasimibe
IBA
03/2005
1
1,2,4-triazine
IBA
11/2004
1
dorzolamide (Trusopt)
FDA Link
Generic
01/2004
1
brinzolamide (Azopt)
FDA Link
01/2004
1
Methyltransferases
IBA
11/2003
1
O(6)-benzylguanine
IBA
11/2003
1
O-(6)-methylguanine
IBA
11/2003
1
Complementary DNA (cDNA)
IBA
11/2003
1
DNA (Deoxyribonucleic Acid)
IBA
11/2003
1
fotemustine (Muphoran)
IBA
11/2003
1
Prodrugs
IBA
10/2003
1
estrone sulfatase
IBA
05/2003
1
Estrogens (Estrogen)
FDA Link
05/2003
1
Steryl-Sulfatase (Steroid Sulfatase)
IBA
05/2003
1
Dehydroepiandrosterone (DHEA)
IBA
05/2003
1
Sugars
IBA
05/2003
1
Bexarotene (LGD1069)
FDA Link
12/2002
Therapy/Procedure
9
Therapeutics
07/2009 - 12/2003
4
Drug Therapy (Chemotherapy)
07/2009 - 05/2003
2
Boron Neutron Capture Therapy
05/2011 - 07/2005
2
Radiotherapy
05/2008 - 07/2005